JRCT ID: jRCT2031220193
Registered date:08/07/2022
Prospective, Post Marketing Surveillance of CAROGRA Tablets
Basic Information
| Recruitment status | Recruiting |
|---|---|
| Health condition(s) or Problem(s) studied | Ulcerative colitis |
| Date of first enrollment | 13/06/2022 |
| Target sample size | 300 |
| Countries of recruitment | |
| Study type | Observational |
| Intervention(s) |
Outcome(s)
| Primary Outcome | Partial Mayo Score |
|---|---|
| Secondary Outcome |
Key inclusion & exclusion criteria
| Age minimum | Not applicable |
|---|---|
| Age maximum | Not applicable |
| Gender | Both |
| Include criteria | Moderate ulcerative colitis (limited to those patients who had inadequate response to 5-aminosalicylic acid) |
| Exclude criteria | - |
Related Information
| Primary Sponsor | Arai Yuki |
|---|---|
| Secondary Sponsor | KISSEI PHARMACEUTICAL CO., LTD. |
| Source(s) of Monetary Support | |
| Secondary ID(s) |
Contact
| Public contact | |
| Name | Yuki Arai |
| Address | 2-1-1, Irifune, Chuo-ku, Tokyo Tokyo Japan 104-0042 |
| Telephone | +81-3-6280-9814 |
| contact_ea@eapharma.co.jp | |
| Affiliation | EA Pharma Co.,Ltd. |
| Scientific contact | |
| Name | Yuki Arai |
| Address | 2-1-1, Irifune, Chuo-ku, Tokyo Tokyo Japan 104-0042 |
| Telephone | +81-3-6280-9814 |
| contact_ea@eapharma.co.jp | |
| Affiliation | EA Pharma Co.,Ltd. |